Olive Leaf Throat Spray Raspberry Spearmint

Manufacturer: Vitality Works, Inc
Effective date: 2025-12-17
Label type: HUMAN OTC DRUG LABEL
Version: 9
Source: full-release
Hydrated at: 2026-06-01 02:36:03

Label at a glance#

ProductOlive Leaf Throat Flavored

Active ingredientBAPTISIA TINCTORIA

Label structure8 sections

Label contents#

Full prescribing information#

Olive Leaf Throat Spray Raspberry Spearmint

OTC - ACTIVE INGREDIENT SECTION

Wild Indigo (Baptisia tinctoria) 4X

Olive Leaf Throat Spray Raspberry Spearmint

INACTIVE INGREDIENT SECTION

Olive Leaf Extract, Raspberry and Spearmint Natural Flavor, USP Purified Water, Vegetable Glycerin, Xylitol

Olive Leaf Throat Spray Raspberry Spearmint

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Olive Leaf Throat Spray Raspberry Spearmint

WARNINGS SECTION

Do not exceed recommended dosage. This product may cause temporary discomfort such as mild burning and stinging in mouth and throat. The use of this container by more than one person may spread infection. For your safety there is a full body seal over bottle printed "sealed for you protection". Do not use if seal is broken or missing.l

Olive Leaf Throat Spray Raspberry Spearmint

INDICATIONS & USAGE SECTION

A homeopathic remedy for the temporary relief of mouth and throat irritations.

Olive Leaf Throat Spray Raspberry Spearmint

DOSAGE & ADMINISTRATION SECTION

Remove protective cap. With your head held upright, hold container close to mouth and depress pump completely. When finished, wipe nozzle clean and replace cap.

Adults and children 13 years and older - 1-3 sprays in mounth every 2-4 hours or as needed.

Children 3-12 - Half the adult dose.

Children under 3 - Consult healthcare professional.

Olive Leaf Throat Spray Raspberry Spearmint

OTC - PURPOSE SECTION

Throat redness and constriction, offensive discharge, painless sore throat, difficulty in swallowing, teeth and gums sore, ulcerated.

Olive Leaf Throat Spray Raspberry Spearmint

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label

Carton

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Barcode	EAN-13	0019277000408	GTIN-13: 0019277000408 EAN-13: 0019277000408 GTIN-12: 019277000408 UPC-A: 019277000408 GTIN storage (14 digits): 00019277000408	throat spray Rasberry full image carton.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
64616-038-01	Olive Leaf ThroatFlavored	30 mL in 1 BOTTLE, SPRAY	SPRAY	30		9
64616-038-02	Olive Leaf ThroatFlavored	1 in 1 CARTON	SPRAY	1		9

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BAPTISIA TINCTORIA	ACTIVE INGREDIENT	5K1UO2888Y	2
BAPTISIA TINCTORIA	ACTIVE MOIETY	5K1UO2888Y	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	2
OLEA EUROPAEA LEAF	INACTIVE INGREDIENT	MJ95C3OH47	2
RASPBERRY SEED OIL	INACTIVE INGREDIENT	9S8867952A	2
SPEARMINT OIL	INACTIVE INGREDIENT	C3M81465G5	2
Water	INACTIVE INGREDIENT	059QF0KO0R	2
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Olive Leaf Throat Flavored
Throat Spray
OLEA EUROPAEA LEAF
XYLITOL
GLYCERIN
WATER
RASPBERRY SEED OIL
SPEARMINT OIL
BAPTISIA TINCTORIA

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
64616-038	64616-038-01, 64616-038-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OLEA EUROPAEA LEAF	MJ95C3OH47	IACT
XYLITOL	VCQ006KQ1E	IACT
GLYCERIN	PDC6A3C0OX	IACT
WATER	059QF0KO0R	IACT
RASPBERRY SEED OIL	9S8867952A	IACT
SPEARMINT OIL	C3M81465G5	IACT
BAPTISIA TINCTORIA	5K1UO2888Y	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 108 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
XYLITOL	XYLITOL	VCQ006KQ1E	PASTE / ORAL		180 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, EXTENDED RELEASE / ORAL		7 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION, EXTENDED RELEASE / ORAL		2000 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SOLUTION / ORAL		21600 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, EXTENDED RELEASE / ORAL		265 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SUSPENSION, EXTENDED RELEASE / ORAL		9000 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	ELIXIR / ORAL		5621 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	POWDER, FOR SUSPENSION / ORAL	4223 mg		Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION / ORAL		32400 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SYRUP / ORAL		16734 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, COATED / ORAL	14.21 mg		Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SUSPENSION, EXTENDED RELEASE / ORAL		9000 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, COATED / ORAL	14.21 mg		Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION, CONCENTRATE / ORAL	200 mg/1ml		Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET / ORAL		42 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	LIQUID / ORAL		2400 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii+dosage form 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	LIQUID / ORAL		2400 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SPRAY / SUBLINGUAL		22 mg	Exact identifier — unii+dosage form 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, COATED / ORAL	1 mg		Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	POWDER, FOR SUSPENSION / ORAL	4223 mg		Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	DROPS / ORAL	300 mg/1ml		Exact identifier — unii+route 63 equally ranked IID candidates
SPEARMINT OIL	SPEARMINT OIL	C3M81465G5	SOLUTION / ORAL	NA		Exact identifier — unii+route 12 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CONCENTRATE / ORAL		1800 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, LIQUID FILLED / ORAL		185 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	PASTE / ORAL		180 mg	Exact identifier — unii+route 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		72 mg	Exact identifier — unii+route 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SUSPENSION / ORAL		1500 mg	Exact identifier — unii+route 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SOLUTION / ORAL		21600 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, EXTENDED RELEASE / ORAL		7 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, FILM COATED / ORAL	1.55 mg		Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET / ORAL	15.04 mg		Exact identifier — unii+route 33 equally ranked IID candidates
SPEARMINT OIL	SPEARMINT OIL	C3M81465G5	SYRUP / ORAL	NA		Exact identifier — unii+route 12 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SYRUP / ORAL		16734 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii+dosage form 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	FILM, SOLUBLE / ORAL		29 mg	Exact identifier — unii+route 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, ORALLY DISINTEGRATING / ORAL		360 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	PASTE / ORAL		3822 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, FILM COATED / ORAL	1.55 mg		Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET / ORAL		42 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	ELIXIR / ORAL		5621 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, EXTENDED RELEASE / ORAL		265 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUSPENSION/ DROPS / ORAL		750 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE / ORAL		3487 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SPRAY / SUBLINGUAL		22 mg	Exact identifier — unii+dosage form 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	FILM, SOLUBLE / ORAL		29 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE / ORAL		3487 mg	Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE, LIQUID FILLED / ORAL		185 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SOLUTION / ORAL		21600 mg	Exact identifier — unii+route 33 equally ranked IID candidates
SPEARMINT OIL	SPEARMINT OIL	C3M81465G5	SYRUP / ORAL	NA		Exact identifier — unii+route 12 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		72 mg	Exact identifier — unii+route 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	FILM, SOLUBLE / ORAL		29 mg	Exact identifier — unii+route 33 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	TABLET, ORALLY DISINTEGRATING / ORAL		360 mg	Exact identifier — unii+route 33 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	ELIXIR / ORAL		5621 mg	Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	POWDER, FOR SUSPENSION / ORAL	4223 mg		Exact identifier — unii+route 33 equally ranked IID candidates
SPEARMINT OIL	SPEARMINT OIL	C3M81465G5	SUSPENSION / ORAL	0.59 mg/20ml		Exact identifier — unii+route 12 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, COATED / ORAL	1 mg		Exact identifier — unii+route 63 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, FILM COATED / ORAL	1.55 mg		Exact identifier — unii+route 63 equally ranked IID candidates
XYLITOL	XYLITOL	VCQ006KQ1E	SPRAY / SUBLINGUAL		22 mg	Exact identifier — unii+dosage form 33 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Olive Leaf Throat Flavored	THROAT SPRAY	Vitality Works, Inc	1301b157-b3bb-4f5c-a67e-15f96707612e	2025-12-17	Warnings	Exact identifier ndc (package): 64616-038-02 ndc (package): 64616-038-01 ndc (product): 64616-038 ndc11 (package): 64616003802 ndc11 (package): 64616003801 spl id: 462eb87d-1776-30bc-e063-6394a90ac676 spl set id: 1301b157-b3bb-4f5c-a67e-15f96707612e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.